Regulation 38 Imports from states other than EEA States / countries other than approved countries for importF4
United Kingdom
This regulation applies in relation to a manufacturer's licence relating to the import of medicinal products.
The licence holder must comply with the conditions set out in this regulation in relation to the import of medicinal products F1from—
in the case of an import into Great Britain, a country other than an approved country for import, or
in the case of an import into Northern Ireland, a country other than an EEA State.
The licence holder must—
comply with the principles and guidelines on good manufacturing practice in the Good Manufacturing Practice Directive in so far as they are relevant to the import of medicinal products; and
ensure that active substances have been used as starting materials in the manufacture of medicinal products, other than special medicinal products, imported from F2, in the case of an import into Great Britain, a country other than an approved country for import and in the case of an import into Northern Ireland, a country other than an EEA State only if those substances have been manufactured or assembled in accordance with F3good manufacturing practice for active substances.
Annotations
Textual amendments
- F1
Reg. 38(2)(a)(b) substituted for words in reg. 38(2) (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 29(3) (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 19(b)); 2020 c. 1, Sch. 5 para. 1(1)
- F2
Words in reg. 38(3)(b) substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 29(4) (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 19(c)); 2020 c. 1, Sch. 5 para. 1(1)
- F3
Words in reg. 38(3)(b) substituted (E.W.S.) (1.10.2015) by The Human Medicines (Amendment) (No. 3) Regulations 2015 (S.I. 2015/1503), regs. 1, 4 and words in reg. 38(3)(b) substituted (N.I.) (1.10.2015) by The Human Medicines (Amendment) (No.3) Regulations 2015 (S.R. 2015/354), regs. 1, 4
- F4
Words in reg. 38 heading inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 29(2) (as substituted by S.I. 2020/1488, reg. 1, Sch. 2 para. 19(a)); 2020 c. 1, Sch. 5 para. 1(1)
Notes on Part 3
Textual amendments
- F1
Pt. 3 heading and Pt. 3 Ch. 1 inserted (20.8.2013) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 4
Notes on Chapter 2
Textual amendments
- F1
Pt. 3 Ch. 2 heading inserted (20.8.2013) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 4